Who we work with

MedTech companies at different stages of development, and the investors who back them.

International manufacturers
Companies with products on the market elsewhere, planning their first US entry.
Companies in clinical development
Teams running feasibility or pivotal trials that need the study to support coverage and launch as well as FDA.
Companies preparing for launch
Companies with clearance or approval in sight that need a launch plan, systems and a field team.
Established companies expanding their portfolio
Device companies adding a product or indication that need specialist help or extra capacity.
Investors and portfolio companies
Investors who want an independent view of what a MedTech company needs to reach the US market.
Clinicians, researchers and inventors
Clinical innovators taking a technology from concept toward early feasibility, regulatory strategy and the evidence US commercialization requires.

Planning for the US market?

Tell us about your technology and where it is in development.